Showing results (321-330 of 364) with videos related to

Sort By:
Pageof 37
The Spanish Journal of Psychology|November 28, 2018
Validation of the Bipolar Spectrum Diagnostic Scale in Mexican Psychiatric PatientsJuan Pablo Sánchez de la Cruz, Ana Fresán, Diana Laura González Moralez, et al.
Neuropsychiatric Disease and Treatment|October 17, 2018
Association between reduced quality of life and depression in patients with type 2 diabetes mellitus: a cohort study in a Mexican populationIsela Esther Juárez-Rojop, Carlos Mario Fortuny-Falconi, Thelma Beatriz González-Castro, et al.
Biomedicines|November 27, 2021
Possible Association of Cholesterol as a Biomarker in Suicide BehaviorThelma Beatriz González-Castro, Alma Delia Genis-Mendoza, Dulce Ivannia León-Escalante, et al.
Annals of Translational Medicine|January 14, 2020
Vortioxetine versus sertraline in metabolic control, distress and depression in Mexican patients with type 2 diabetesCarlos Alfonso Tovilla-Zárate, Antonia Pérez-Mandujano, Iris Rubí Ramírez-González, et al.
Fish Physiology and Biochemistry|June 26, 2021
Changes in digestive enzyme activities during the early ontogeny of the South American cichlid (Cichlasoma dimerus)Francisco Javier Toledo-Solís, Andrea Guadalupe Hilerio-Ruiz, Tomás Delgadin, et al.
BMC Infectious Diseases|March 12, 2021
Diagnostic accuracy of symptoms as a diagnostic tool for SARS-CoV 2 infection: a cross-sectional study in a cohort of 2,173 patientsCarlos Alfonso Romero-Gameros, Tania Colin-Martínez, Salomón Waizel-Haiat, et al.
Clinical Rheumatology|May 20, 2018
Genetic association analysis of Osteopontin and Matrix Gla Protein genes polymorphisms with primary knee osteoarthritis in Mexican populationVerónica Marusa Borgonio-Cuadra, Norma Celia González-Huerta, Emma Xochitl Rojas-Toledo, et al.
Laryngoscope Investigative Otolaryngology|December 28, 2020
Evaluation of predictive value of olfactory dysfunction, as a screening tool for COVID-19Carlos Alfonso Romero-Gameros, Salomón Waizel-Haiat, Victoria Mendoza-Zubieta, et al.
Journal of Psychiatric Research|April 23, 2023
Assessment of cognitive impairment and depressive signs in patients with type 2 diabetes treated with metformin from Southeast Mexico: A cross-sectional studyGerman Alberto Nolasco-Rosales, Guillermo Efrén Villar-Juárez, Daniel Arturo Pérez-Osorio, et al.
Pageof 37